Centiva Capital »

Pacira Pharmaceuticals shares owned by Centiva Capital

Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Pacira Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pacira Pharmaceuticals held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacira Pharmaceuticals by Centiva Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $398k 27k 15.05
2022-12-31 $251k 6.5k 38.61
2021-09-30 $417k 7.5k 55.89

More positions owned by Centiva Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Ishares Tr 7-10 Yr Trsy Bd Put Option (IEF)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr National Mun Etf (MUB)
Agnc Invt Corp Com reit (AGNC)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Boeing Company Call Option (BA)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Centiva Capital

Top funds holding Pacira Pharmaceuticals

BlackRock
Vanguard Group
Pacer Advisors
State Street Corporation
Renaissance Technologies
D. E. Shaw & Co
Dimensional Fund Advisors
Doma Perpetual Capital Management
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Invesco
Jpmorgan Chase & Co
Millennium Management
Citadel Advisors
Cubist Systematic Strategies

View all funds holding Pacira Pharmaceuticals